Randall Division of Cell and Molecular Biophysics, King's College London, London, United Kingdom.
PLoS One. 2010 Jun 28;5(6):e11338. doi: 10.1371/journal.pone.0011338.
Type II DNA topoisomerases are ubiquitous enzymes with essential functions in DNA replication, recombination and transcription. They change DNA topology by forming a transient covalent cleavage complex with a gate-DNA duplex that allows transport of a second duplex though the gate. Despite its biological importance and targeting by anticancer and antibacterial drugs, cleavage complex formation and reversal is not understood for any type II enzyme. To address the mechanism, we have used X-ray crystallography to study sequential states in the formation and reversal of a DNA cleavage complex by topoisomerase IV from Streptococcus pneumoniae, the bacterial type II enzyme involved in chromosome segregation. A high resolution structure of the complex captured by a novel antibacterial dione reveals two drug molecules intercalated at a cleaved B-form DNA gate and anchored by drug-specific protein contacts. Dione release generated drug-free cleaved and resealed DNA complexes in which the DNA gate instead adopts an unusual A/B-form helical conformation with a Mg(2+) ion repositioned to coordinate each scissile phosphodiester group and promote reversible cleavage by active-site tyrosines. These structures, the first for putative reaction intermediates of a type II topoisomerase, suggest how a type II enzyme reseals DNA during its normal reaction cycle and illuminate aspects of drug arrest important for the development of new topoisomerase-targeting therapeutics.
II 型 DNA 拓扑异构酶是普遍存在的酶,在 DNA 复制、重组和转录中具有重要功能。它们通过与带有门控 DNA 双链的瞬态共价切割复合物形成来改变 DNA 拓扑结构,从而允许第二个双链体穿过门控体进行转运。尽管其具有生物学重要性,并且是抗癌和抗菌药物的靶向目标,但对于任何 II 型酶,其切割复合物的形成和逆转机制仍不清楚。为了解决这一问题,我们使用 X 射线晶体学研究了肺炎链球菌(参与染色体分离的细菌 II 型酶)拓扑异构酶 IV 形成和逆转 DNA 切割复合物的连续状态。通过一种新型抗菌二酮化合物捕获的复合物的高分辨率结构揭示了两个药物分子插入在切割的 B 型 DNA 门控体中,并通过药物特异性的蛋白质接触来固定。二酮化合物的释放生成了无药物的切割和重新封闭的 DNA 复合物,其中 DNA 门控体采用了一种不寻常的 A/B 型螺旋构象,Mg(2+)离子重新定位以协调每个切口磷酸二酯基团,并通过活性位点酪氨酸促进可逆切割。这些结构是第一个 II 型拓扑异构酶的假定反应中间体,说明了 II 型酶如何在其正常反应循环中重新封闭 DNA,并阐明了药物阻断的一些方面,这些方面对于开发新的拓扑异构酶靶向治疗方法很重要。